EVH Evolent Health Inc

Price (delayed)

$31

Market cap

$2.84B

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$0.39

Enterprise value

$2.97B

Evolent Health delivers proven clinical and administrative solutions that improve whole-person health while making health care simpler and more affordable. Its solutions encompass total cost of care management, specialty care ...

Highlights
Evolent Health's net income has surged by 88% YoY and by 12% QoQ
The EPS has soared by 87% YoY and by 11% QoQ
The quick ratio has grown by 6% from the previous quarter but it has contracted by 2.6% YoY
The debt has increased by 23% QoQ and by 16% YoY
The company's equity fell by 12% QoQ

Key stats

What are the main financial stats of EVH
Market
Shares outstanding
91.59M
Market cap
$2.84B
Enterprise value
$2.97B
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
4.61
Price to sales (P/S)
2.8
EV/EBIT
N/A
EV/EBITDA
60.64
EV/Sales
3
Earnings
Revenue
$989.94M
EBIT
-$10.74M
EBITDA
$49.06M
Free cash flow
$1.92M
Per share
EPS
-$0.39
Free cash flow per share
$0.02
Book value per share
$6.73
Revenue per share
$11.06
TBVPS
$7.16
Balance sheet
Total assets
$1.34B
Total liabilities
$727.94M
Debt
$345.4M
Equity
$611.21M
Working capital
$80.92M
Liquidity
Debt to equity
0.57
Current ratio
1.21
Quick ratio
1.12
Net debt/EBITDA
2.76
Margins
EBITDA margin
5%
Gross margin
27.3%
Net margin
-3.3%
Operating margin
-2.3%
Efficiency
Return on assets
-2.5%
Return on equity
-5.2%
Return on invested capital
-3.1%
Return on capital employed
-1.1%
Return on sales
-1.1%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

EVH stock price

How has the Evolent Health stock price performed over time
Intraday
0.19%
1 week
2.82%
1 month
5.48%
1 year
48.11%
YTD
12.03%
QTD
-4.02%

Financial performance

How have Evolent Health's revenue and profit performed over time
Revenue
$989.94M
Gross profit
$270.49M
Operating income
-$23.19M
Net income
-$33.14M
Gross margin
27.3%
Net margin
-3.3%
The operating margin has soared by 92% YoY and by 51% from the previous quarter
The company's operating income has surged by 91% YoY and by 45% QoQ
The net margin has soared by 89% YoY and by 20% QoQ
Evolent Health's net income has surged by 88% YoY and by 12% QoQ

Growth

What is Evolent Health's growth rate over time

Valuation

What is Evolent Health stock price valuation
P/E
N/A
P/B
4.61
P/S
2.8
EV/EBIT
N/A
EV/EBITDA
60.64
EV/Sales
3
The EPS has soared by 87% YoY and by 11% QoQ
EVH's price to book (P/B) is 142% higher than its 5-year quarterly average of 1.9 and 15% higher than its last 4 quarters average of 4.0
The company's equity fell by 12% QoQ
The price to sales (P/S) is 33% higher than the 5-year quarterly average of 2.1 and 8% higher than the last 4 quarters average of 2.6
The revenue has grown by 9% from the previous quarter and by 8% YoY

Efficiency

How efficient is Evolent Health business performance
The ROS has soared by 96% YoY and by 15% QoQ
EVH's return on invested capital has surged by 94% year-on-year and by 11% since the previous quarter
The ROE has soared by 88% YoY and by 12% from the previous quarter
Evolent Health's return on assets has surged by 87% YoY and by 14% QoQ

Dividends

What is EVH's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for EVH.

Financial health

How did Evolent Health financials performed over time
The company's total assets is 84% higher than its total liabilities
The quick ratio has grown by 6% from the previous quarter but it has contracted by 2.6% YoY
The company's total assets fell by 6% QoQ but it rose by 2.6% YoY
The debt is 43% lower than the equity
EVH's debt to equity is up by 43% since the previous quarter and by 19% year-on-year
The debt has increased by 23% QoQ and by 16% YoY

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.